Citadel Advisors’s InflaRx IFRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.3K | Sell |
26,037
-36,549
| -58% | -$34.5K | ﹤0.01% | 12635 |
|
|
2025
Q4 | $63.2K | Sell |
62,586
-40,365
| -39% | -$50.1K | ﹤0.01% | 11920 |
|
|
2025
Q3 | $138K | Buy |
+102,951
| New | +$109K | ﹤0.01% | 11598 |
|
|
2025
Q2 | – | Sell |
-432,822
| Closed | -$512K | – | 13682 |
|
|
2025
Q1 | $441K | Buy |
432,822
+381,908
| +750% | +$720K | ﹤0.01% | 8749 |
|
|
2024
Q4 | $126K | Buy |
50,914
+27,973
| +122% | +$53.8K | ﹤0.01% | 11123 |
|
|
2024
Q3 | $35.1K | Sell |
22,941
-39,484
| -63% | -$60.1K | ﹤0.01% | 12284 |
|
|
2024
Q2 | $109K | Sell |
62,425
-35,559
| -36% | -$52.2K | ﹤0.01% | 10805 |
|
|
2024
Q1 | $151K | Buy |
97,984
+85,121
| +662% | +$139K | ﹤0.01% | 10755 |
|
|
2023
Q4 | $21K | Sell |
12,863
-5
| -0% | -$9 | ﹤0.01% | 12584 |
|
|
2023
Q3 | $38.3K | Buy |
+12,868
| New | +$49K | ﹤0.01% | 12044 |
|
|
2023
Q2 | – | Sell |
-412
| Closed | -$1.84K | – | 14755 |
|
|
2023
Q1 | $799 | Sell |
412
-9,251
| -96% | -$20K | ﹤0.01% | 14413 |
|
|
2022
Q4 | $30K | Buy |
+9,663
| New | +$24.6K | ﹤0.01% | 12751 |
|
|
2022
Q2 | – | Sell |
-29,363
| Closed | -$54K | – | 13426 |
|
|
2022
Q1 | $54K | Sell |
29,363
-26,711
| -48% | -$83.2K | ﹤0.01% | 12745 |
|
|
2021
Q4 | $267K | Buy |
+56,074
| New | +$225K | ﹤0.01% | 11180 |
|
|
2021
Q3 | – | Sell |
-10,836
| Closed | -$28.5K | – | 14194 |
|
|
2021
Q2 | $32K | Buy |
+10,836
| New | +$35.9K | ﹤0.01% | 13467 |
|
|
2021
Q1 | – | Sell |
-28,271
| Closed | -$143K | – | 13426 |
|
|
2020
Q4 | $143K | Buy |
+28,271
| New | +$127K | ﹤0.01% | 9978 |
|
|
2020
Q2 | – | Sell |
-551,274
| Closed | -$3.58M | – | 10122 |
|
|
2020
Q1 | $2.11M | Buy |
551,274
+445,472
| +421% | +$1.65M | ﹤0.01% | 4064 |
|
|
2019
Q4 | $419K | Buy |
105,802
+5,867
| +6% | +$17.1K | ﹤0.01% | 7089 |
|
|
2019
Q3 | $247K | Hold |
99,935
| – | – | ﹤0.01% | 7858 |
|
|
2019
Q2 | $316K | Buy |
99,935
+4,840
| +5% | +$153K | ﹤0.01% | 7508 |
|
|
2019
Q1 | $3.59M | Buy |
95,095
+64,801
| +214% | +$2.41M | ﹤0.01% | 3473 |
|
|
2018
Q4 | $1.1M | Sell |
30,294
-49,293
| -62% | -$1.52M | ﹤0.01% | 5169 |
|
|
2018
Q3 | $2.73M | Sell |
79,587
-110,593
| -58% | -$3.57M | ﹤0.01% | 3876 |
|
|
2018
Q2 | $6.13M | Buy |
190,180
+56,309
| +42% | +$1.94M | ﹤0.01% | 2500 |
|
|
2018
Q1 | $3.86M | Buy |
+133,871
| New | +$3.53M | ﹤0.01% | 2781 |
|
Other funds holding IFRX
SCM
6CM
EP
TC
Citadel Advisors's IFRX Position: Q1 2026 in Review
Citadel Advisors reduced its InflaRx (IFRX) stake by 58% in Q1 2026, selling an estimated $34.5K and leaving 26,037 shares worth $23.3K. The position accounts for ﹤0.01% of the portfolio, ranked #12635.
Citadel Advisors first reported a position in IFRX in Q1 2018 and has held it in 25 quarters since. The position peaked at $6.13M in Q2 2018. 35 funds tracked by Wall St. Rank hold IFRX as of Q1 2026.
- Citadel Advisors held 26,037 shares of InflaRx worth $23.3K as of Q1 2026.
- Citadel Advisors sold 36,549 InflaRx shares in Q1 2026, an estimated $34.5K.
- InflaRx made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12635 holding.
- Citadel Advisors first reported a position in InflaRx in Q1 2018 and has held it in 25 quarters since.
- Citadel Advisors's InflaRx position peaked at $6.13M in Q2 2018.
- 35 funds tracked by Wall St. Rank held InflaRx as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.